Board ReviewOB/GYNComparison

Gestational Hypertension vs Preeclampsia on Step 2 CK: Up to Half Will Progress

Gestational hypertension vs preeclampsia for Step 2 CK: the test that separates them, the trials behind 37 and 34 weeks, six worked versions and the traps.

Step 2 CK outlinePregnancy, Childbirth & the PuerperiumDiagnosisLaboratory/Diagnostic StudiesMixed ManagementObstetrics & Gynecology

Contents
  1. The dividing line is one measurement, and protein is only one way across it
  2. Three tempting answers, and the trial evidence against each
  3. One patient, six versions: the detail that flips the answer
  4. Four disguises: when preeclampsia does not look like preeclampsia
  5. What's new: a blood test that forecasts the next two weeks
  6. 60-second recall
  7. FAQ
  8. Sources

Up to 50% of patients with gestational hypertension eventually develop proteinuria or end-organ dysfunction that makes the diagnosis preeclampsia, according to ACOG, usually within 1 to 3 weeks.

So a new pressure of 146/94 at 35 weeks is a question, not a diagnosis. In a typical exam-style stem the patient feels fine, the numbers are mild, and the answer choices offer magnesium, IV labetalol or delivery today. The point goes to the student who measures before acting.

The same habit matters on the wards. Under-call it and you miss the patient heading for a seizure; over-call it and a late-preterm baby arrives early for no reason. For the step-by-step flowchart, use today's Board Review algorithm. This review covers the reasoning, the trials behind each rule and the presentations that hide the disease.

The dividing line is one measurement, and protein is only one way across it

Gestational hypertension is a systolic pressure of 140 mm Hg or more or a diastolic of 90 or more, on two occasions at least 4 hours apart, after 20 weeks, in someone whose pressure was normal before, per ACOG Practice Bulletin 222.

Preeclampsia is that same hypertension plus proteinuria: 300 mg or more in 24 hours, or a protein-to-creatinine ratio of 0.3 or more. A dipstick of 2+ counts only when no quantitative test is available, so a trace result settles nothing.

Protein is not required. New hypertension with any new end-organ sign is also preeclampsia: platelets below 100,000/mm3, creatinine above 1.1 mg/dL or doubled, transaminases twice normal, pulmonary edema, a new headache unresponsive to medication, or visual disturbances.

Those signs double as severe features, along with a pressure of 160/110 or more and severe persistent right upper quadrant or epigastric pain. One rule catches students out: ACOG says gestational hypertension with severe-range pressures "should be managed with the same approach as for women with severe preeclampsia," even with no protein at all.

Three tempting answers, and the trial evidence against each

Every wrong option in a mild-range stem fails for a reason you can cite.

Magnesium sulfate: its benefit is concentrated in severe disease

In the Magpie trial, 10,141 women with preeclampsia in 33 countries were randomized to magnesium sulfate or placebo. Magnesium cut eclampsia by 58% (0.8% vs 1.9%, or 11 fewer cases per 1,000 women), but 24% reported side effects, against 5% on placebo.

ACOG's bulletin puts the trade-off in numbers: 129 asymptomatic women need treatment to prevent one seizure, against 36 when symptoms such as severe headache or blurred vision are present. For preeclampsia without severe features, it says there is no consensus on prophylactic magnesium.

IV labetalol: built for 160/110 that lasts 15 minutes

Acute-onset severe hypertension, confirmed as persistent for 15 minutes or more, is treated within 30 to 60 minutes with IV labetalol, IV hydralazine or immediate-release oral nifedipine. A reading of 146/94 meets none of that. ACE inhibitors and ARBs are never the answer: StatPearls lists both as contraindicated in pregnancy.

Delivery today, or a recheck in a month: two Dutch trials set the timing

HYPITAT-II randomized 703 women with non-severe hypertensive disorders at 34 to 37 weeks. Immediate delivery lowered the maternal composite from 3.1% to 1.1%, a difference that was not statistically significant, and more than tripled neonatal respiratory distress syndrome (5.7% vs 1.7%).

At term the balance flips. In HYPITAT, 756 women at 36 to 41 weeks with gestational hypertension or mild preeclampsia were randomized; a poor maternal outcome occurred in 31% after induction versus 44% with expectant monitoring (relative risk 0.71). ACOG recommends delivery at 37 0/7 weeks without severe features, and at or beyond 34 0/7 weeks once severe features appear.

Waiting is not the same as reassurance. ACOG notes that preeclampsia without severe features can turn severe within days, so a "recheck in 4 weeks" leaves a progressing disease unwatched.

One patient, six versions: the detail that flips the answer

Start with an original base case: a 32-year-old in her second pregnancy at 35 weeks, BP 146/94 and then 144/92 four hours later, first-trimester BP 116/74, no symptoms. Change one detail at a time.

Same patient, one change per row
The changeWhat she hasNext step
Protein-to-creatinine ratio 0.12; normal platelets, creatinine and liver enzymesGestational hypertensionMonitor mother and fetus; deliver at 37 0/7 weeks
Ratio 0.46, labs normalPreeclampsia without severe featuresThe same plan: monitoring, delivery at 37 0/7 weeks
Ratio 0.12, platelets 84,000/mm3Preeclampsia with severe features, no proteinuria neededMagnesium, BP control, delivery once she is stable (she is past 34 weeks)
BP 166/112, still 164/110 fifteen minutes later; labs normalGestational hypertension with severe-range pressureIV labetalol, IV hydralazine or oral nifedipine within 30–60 minutes, then manage as severe preeclampsia
The same readings and proteinuria at 16 weeksToo early for typical preeclampsiaLook for the alternative diagnoses ACOG names: molar pregnancy, kidney or autoimmune disease
No high reading ever recorded, then a tonic-clonic seizure at 36 weeksEclampsia is still the first diagnosis to treatMagnesium sulfate

Rows 1 and 2 share a plan, and that is the quiet lesson: without severe features, the label changes and the timing does not.

Four disguises: when preeclampsia does not look like preeclampsia

  • No protein. Row 3 above: a normal ratio does not clear a patient with low platelets, a rising creatinine or doubled transaminases.
  • Before 20 weeks. ACOG advises considering alternative diagnoses at that stage, including molar pregnancy.
  • No hypertension. In a UK nationwide analysis cited by ACOG, 38% of eclamptic seizures occurred without any prior documented hypertension or proteinuria. HELLP syndrome lacks hypertension or proteinuria in up to 15% of patients.
  • After delivery. In 30% of cases, HELLP is first expressed or progresses postpartum, and magnesium continues for 24 hours after delivery. ACOG notes that other diagnoses may be more likely when a new seizure starts more than 48 to 72 hours after delivery.

What's new: a blood test that forecasts the next two weeks

The newest tool measures an angiogenic imbalance that rises before preeclampsia appears: the ratio of sFlt-1 to placental growth factor (PlGF).

In PROGNOSIS (NEJM, 2016), among 550 validation patients with suspected preeclampsia at 24 to 36 weeks, a ratio of 38 or lower had a 99.3% negative predictive value for preeclampsia in the following week. A higher ratio was a weak rule-in, with a 36.7% positive predictive value within 4 weeks. Roche Diagnostics funded the study.

The U.S. study, PRAECIS, enrolled patients hospitalized with hypertensive disorders at 23 to 35 weeks across 18 centers. A ratio of 40 or more predicted preeclampsia with severe features within 2 weeks with a 65% positive and 96% negative predictive value, and an area under the curve of 0.92, versus under 0.75 for standard tests.

Thermo Fisher, which co-funded PRAECIS, announced FDA clearance of its sFlt-1 and PlGF assays on May 19, 2023, for hospitalized patients with hypertensive disorders of pregnancy, to be used with other tests and clinical assessment.

The caveat: the ratio stratifies risk and is not part of the Practice Bulletin 222 criteria. The diagnosis still rests on pressures, protein, platelets, creatinine, liver enzymes and symptoms.

Gestational hypertension and preeclampsia share a plan until a number says otherwise. Measure the protein, check the labs, time the delivery, and save magnesium for the patient who needs it.

Today's MedRise study set: walk every branch in the Preeclampsia Algorithm for the OB/GYN Shelf, fix the habit behind repeat misses with Keep Missing Preeclampsia Questions on Step 2 CK?, and hear the Daily Case 003 rapid review on the MedRise Podcast. Test yourself with today's Daily Case on Instagram @medrise_ at 7:30 PM Central, then explain the 37- and 34-week rules out loud in MedRise Viva. More exam resources are on the MedRise student page.

60-second recall

Say each answer out loud before you reveal it, then mark yourself. Retrieval, not rereading, is what makes it stick.

  1. 1Gestational hypertension threshold
    140/90 or more on two readings at least 4 hours apart, after 20 weeks, with normal pressure before.
    Did you get it?
  2. 2Proteinuria that makes it preeclampsia
    Protein-to-creatinine ratio 0.3 or more, or 300 mg or more in 24 hours (dipstick 2+ only if nothing quantitative is available).
    Did you get it?
  3. 3Preeclampsia without proteinuria
    New hypertension plus platelets below 100,000/mm3, creatinine above 1.1 mg/dL, doubled transaminases, pulmonary edema, refractory new headache or visual symptoms.
    Did you get it?
  4. 4Share of gestational hypertension that progresses to preeclampsia
    Up to 50%, more likely when diagnosed before 32 weeks.
    Did you get it?
  5. 5Gestational hypertension with pressures of 160/110 or more
    Managed like preeclampsia with severe features.
    Did you get it?
  6. 6Severe pressure that persists 15 minutes
    IV labetalol, IV hydralazine or immediate-release oral nifedipine within 30–60 minutes.
    Did you get it?
  7. 7Delivery without severe features
    37 0/7 weeks.
    Did you get it?
  8. 8Delivery with severe features at 34 weeks or later
    After the mother is stabilized.
    Did you get it?
  9. 9Magnesium sulfate after delivery
    Continue for 24 hours.
    Did you get it?
  10. 10Eclamptic seizures with no prior documented hypertension or proteinuria
    38% in a UK nationwide analysis.
    Did you get it?

FAQ

What is the difference between gestational hypertension and preeclampsia?

Both start with new pressures of 140/90 or more after 20 weeks. Preeclampsia adds proteinuria or a new end-organ sign. Without severe features, both are delivered at 37 0/7 weeks.

Can you have preeclampsia without protein in the urine?

Yes. New hypertension with low platelets, a raised creatinine, doubled transaminases, pulmonary edema, a new headache unresponsive to medication or visual symptoms meets the ACOG definition with no proteinuria.

Does gestational hypertension always turn into preeclampsia?

No, but up to half of patients progress, more often when the hypertension starts before 32 weeks, which is why monitoring continues until delivery.

Should mild hypertension in pregnancy be treated with medication?

ACOG's urgent threshold is 160/110 sustained for 15 minutes. For mild chronic hypertension, the 2022 CHAP trial found that targeting below 140/90 lowered a composite of severe preeclampsia, indicated birth before 35 weeks, abruption and fetal or neonatal death (30.2% vs 37.0%) without raising small-for-gestational-age births. CHAP studied chronic hypertension, not gestational hypertension.

Sources

  1. American College of Obstetricians and Gynecologists. Gestational Hypertension and Preeclampsia. ACOG Practice Bulletin No. 222. Obstet Gynecol. 2020;135(6):e237-e260. ACOG
  2. Karrar SA, Martingano DJ, Hong PL. Preeclampsia. StatPearls. Updated February 25, 2024. NCBI Bookshelf
  3. Luger RK, Kight BP. Hypertension in Pregnancy. StatPearls. Updated October 3, 2022. NCBI Bookshelf
  4. Altman D, et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial. Lancet. 2002;359(9321):1877-1890. DOI
  5. Koopmans CM, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT). Lancet. 2009;374(9694):979-988. DOI
  6. Broekhuijsen K, et al. Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II). Lancet. 2015;385(9986):2492-2501. DOI
  7. Zeisler H, et al. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl J Med. 2016;374(1):13-22. DOI
  8. Thadhani R, et al. Circulating angiogenic factor levels in hypertensive disorders of pregnancy. NEJM Evid. 2022;1(12):EVIDoa2200161. DOI
  9. Tita AT, et al. Treatment for mild chronic hypertension during pregnancy (CHAP). N Engl J Med. 2022;386(19):1781-1792. DOI
  10. Thermo Fisher Scientific. FDA clearance of immunoassays to aid in the risk assessment of preeclampsia. Press release, May 19, 2023. Thermo Fisher

MedRise Board Review is educational content for exam preparation only. It is not medical advice and does not replace current guidelines, your school's materials or clinical judgment.

Learned something the hard way on a shelf or on the wards?

Write it up for MedRise Perspectives: 600 to 1,200 words, published under your name, with a decision usually within one day.

Book a free strategy call

Ten minutes to look at your exam date, your scores and what is getting in the way.